Public Profile

Ha Tay Pharmaceutical JSC

Ha Tay Pharmaceutical JSC, commonly referred to as Ha Tay Pharma, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 1976, the company has made significant strides in the production and distribution of high-quality pharmaceutical products across various regions in Vietnam. Specialising in the development of generic medicines, Ha Tay Pharma offers a diverse range of products, including tablets, capsules, and injectables, distinguished by their adherence to stringent quality standards. The company has achieved notable milestones, including certifications that affirm its commitment to excellence in manufacturing practices. With a strong market presence, Ha Tay Pharmaceutical JSC is recognised for its innovative approach and dedication to improving healthcare outcomes, positioning itself as a trusted name in the Vietnamese pharmaceutical landscape.

DitchCarbon Score

How does Ha Tay Pharmaceutical JSC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

10

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

Ha Tay Pharmaceutical JSC's score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.

44%

Ha Tay Pharmaceutical JSC's reported carbon emissions

Ha Tay Pharmaceutical JSC, headquartered in Vietnam, currently does not have available data on carbon emissions, as no specific emissions figures have been reported. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical sector are increasingly focusing on sustainability and climate action, often setting ambitious targets to reduce their carbon footprint. However, without specific information from Ha Tay Pharmaceutical JSC, it is challenging to provide a detailed overview of their climate commitments or initiatives.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ha Tay Pharmaceutical JSC's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Ha Tay Pharmaceutical JSC is headquartered in VN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Ha Tay Pharmaceutical JSC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Similar Organizations

Sanofi

FR
Chemicals nec
Updated 4 days ago

SPM Corporation

VN
Chemicals nec
Updated 21 days ago

Glaxosmithkline

GB
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers